SCHEMBL1961233

SCHEMBL1961233

CCCCCC1CCC(c2ccc(-c3ccc(C(=O)Nc4ccc(B5OC(C)(C)C(C)(C)O5)c(C)c4)cc3)cc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
DGAT1 O75907 1/20 0.39
MAPK14 Q16539 9/20 0.39
HDAC3 O15379 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HSPB1 P04792 1/20 0.38
CYP2C9 P11712 1/20 0.37
P2RY14 Q15391 1/20 0.37
LDLR P01130 1/20 0.36
CXCR2 P25025 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1962070 0.97 MAPT (0.44) ALDH1A1LMNAMAPTMAPK14HDAC3
SCHEMBL1962066 0.97 MAPT (0.44) ALDH1A1LMNAMAPTMAPK14HDAC3
SCHEMBL1961254 0.96 ALDH1A1 (0.42) ALDH1A1LMNAMAPTDGAT1MAPK14
SCHEMBL1961256 0.96 ALDH1A1 (0.42) ALDH1A1LMNAMAPTDGAT1MAPK14
SCHEMBL2015238 0.87 CA1 (0.48) ALDH1A1LMNAMAPTDGAT1HDAC3
SCHEMBL2015239 0.87 CA1 (0.48) ALDH1A1LMNAMAPTDGAT1HDAC3
SCHEMBL1960036 0.87 CA1 (0.48) ALDH1A1LMNAMAPTDGAT1HDAC3
SCHEMBL1958394 0.87 CA1 (0.48) ALDH1A1LMNAMAPTDGAT1HDAC3
SCHEMBL1962051 0.87 MAPT (0.42) ALDH1A1LMNAMAPTHDAC3HDAC11
SCHEMBL12125151 0.85 ALDH1A1 (0.51) ALDH1A1LMNAMAPTDGAT1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3621958-B9 PHOTOCHROMIC INDENO FUSED PHENANTHRENOPYRAN COMPOUNDS TRANSITIONS OPTICAL LTD (IE) 2024-09-25 EP disclosed
EP-3621958-B1 PHOTOCHROMIC INDENO FUSED PHENANTHRENOPYRAN COMPOUNDS TRANSITIONS OPTICAL LTD (IE) 2024-07-10 EP disclosed
CN-110730778-B Photochromic indeno-fused phenanthropyran compounds 光学转变有限公司 2023-09-12 CN disclosed
US-11453654-B2 Photochromic indeno fused phenanthrenopyran compounds TRANSITIONS OPTICAL, LTD. (IE) 2022-09-27 US disclosed
US-20200048216-A1 Photochromic Indeno Fused Phenanthrenopyran Compounds TRANSITIONS OPTICAL, LTD. (IE) 2020-02-13 US disclosed
CN-110730778-A Photochromic indeno-fused phenanthropyran compounds 光学转变有限公司 2020-01-24 CN disclosed
EP-3045971-A1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS Transitions Optical, Inc. (US) 2016-07-20 EP disclosed
EP-2652553-B1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS TRANSITIONS OPTICAL INC (US) 2016-04-06 EP disclosed
EP-2652552-B9 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS TRANSITIONS OPTICAL INC (US) 2016-02-17 EP disclosed
EP-2652552-B1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS TRANSITIONS OPTICAL INC (US) 2015-09-02 EP disclosed
EP-2652553-A1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS Transitions Optical, Inc. (US) 2013-10-23 EP disclosed
US-8545984-B2 Photochromic compounds and compositions TRANSITIONS OPTICAL, INC. (US) 2013-10-01 US disclosed
US-8518546-B2 Photochromic compounds and compositions TRANSITIONS OPTICAL, INC. (US) 2013-08-27 US disclosed
WO-2012082383-A1 PHOTOCHROMIC COMPOUNDS AND COMPOSITIONS TRANSITIONS OPTICAL, INC. (US) 2012-06-21 WO disclosed
US-20110143141-A1 Photochromic compounds and compositions TRANSITIONS OPTICAL, INC. (US) 2011-06-16 US disclosed
US-20110129678-A1 Photochromic compounds and compositions TRANSITIONS OPTICAL, INC. (US) 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048216-A1 Photochromic Indeno Fused Phenanthrenopyran Compounds ALDH1A2, RB1, INCENP ALDH1A1 433/4885LMNA 1798/4885MAPT 1822/4885
US-20110143141-A1 Photochromic compounds and compositions CCNA1, CRY1, CCNT1 ALDH1A1 43/4885LMNA 230/4885MAPT 785/4885
US-20110129678-A1 Photochromic compounds and compositions CRY2, CRY1, PPOX ALDH1A1 1243/4885LMNA 657/4885MAPT 573/4885
US-11453654-B2 Photochromic indeno fused phenanthrenopyran compounds ALDH1A2, RB1, INCENP ALDH1A1 433/4885LMNA 1798/4885MAPT 1822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.